FY2025 Earnings Forecast for PRQR Issued By Chardan Capital
ProQR Therapeutics (NASDAQ:PRQR – Free Report) – Analysts at Chardan Capital boosted their FY2025 EPS estimates for ProQR Therapeutics in a report released on Monday, March 24th. Chardan Capital analyst K. Nakae now expects that the biopharmaceutical company will post earnings of ($0.33) per share for the year, up from their previous estimate of ($0.34). […]
ProQR Therapeutics (NASDAQ:PRQR – Free Report) – Analysts at Chardan Capital boosted their FY2025 EPS estimates for ProQR Therapeutics in a report released on Monday, March 24th. Chardan Capital analyst K. Nakae now expects that the biopharmaceutical company will post earnings of ($0.33) per share for the year, up from their previous estimate of ($0.34). […]
